Many people with type 1 or type 2 diabetes use NNS as a replacement for nutritive sweeteners to control their carbohydrate and energy intake. Health outcomes associated with NNS use in diabetes are unknown.
The date of the last search of all databases except for Scopus was May We last searched Scopus in January We did not apply any language restrictions. Trials with concomitant behaviour-changing interventions, such as diet, exercise, or both, were eligible for inclusion, given that the concomitant interventions were the same in the intervention and comparator groups.
The intervention duration ranged from 4 to 10 months. We judged none of these trials as at low risk of bias for all 'Risk of bias' domains; most of the included trials did not report the method of randomisation.
Three trials compared the effects of a dietary supplement containing NNS with sugar: glycosylated haemoglobin A1c HbA1c was 0. The MD in weight change was None of the trials with sugar as comparator reported on adverse events. Five trials compared NNS with placebo.
Fokozott stressz esetén a szív meghibásodik, és a tachycardia bizonyos tünetei Mi az a diabetes mellitus DM? Ez a betegség az endokrin csoportba tartozik.
One trial compared NNS with a nutritive low-calorie sweetener tagatose. HbA1c was 0.
This trial did not report body weight data and adverse events. The included trials did not report data on health-related quality of life, diabetes complications, all-cause mortality, or socioeconomic effects.
Data on health-related quality of life, diabetes complications, all-cause mortality, and socioeconomic effects are lacking.